Safety and Efficacy of Ramelteon in Healthy Subjects

Status:
Completed

Trial end date:
2005-05-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the phase-advance in circadian rhythms in healthy adults subjects taking ramelteon, once daily (QD).

Phase 2

Takeda